Krystal Biotech, Inc.

Over the last 90 days, Krystal Biotech (KRYS) has reported zero cyber incidents and zero red-flag 8-K filings—a clean signal in our real-time monitoring window. However, absence of recent events doesn't indicate absence of risk; the biotech sector faces persistent pressures around capital intensity and shareholder dilution that require deeper structural analysis. The full $49 Report extends the lookback to 12 months, calculates dilution risk scoring, maps the complete financing history, and flags AI-detected risk signals that don't appear in headline filings. The full $49 Report adds dilution trajectory analysis, 12-month red-flag context, and AI-scored risk signals across capital structure and clinical pipeline exposure.